Hisamitsu Pharmaceutical Co., Inc. Unsponsored ADR logo

Hisamitsu Pharmaceutical Co., Inc. Unsponsored ADR (HTSUY)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
2. 94
0
0%
$
839.03M Market Cap
- P/E Ratio
0.76% Div Yield
0 Volume
- Eps
$ 2.94
Previous Close
Add Transaction
Day Range
2.94 2.94
Year Range
2.94 7.1
Want to track HTSUY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HTSUY closed yesterday higher at $2.94, an increase of 0% from Friday's close, completing a monthly increase of 0% or $0. Over the past 12 months, HTSUY stock lost -51%.
HTSUY is not paying dividends to its shareholders.
The last earnings report, released on Apr 08, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Hisamitsu Pharmaceutical Co., Inc. Unsponsored ADR has completed 1 stock splits, with the recent split occurring on Sep 06, 2017.
The company's stock is traded on one exchange.

HTSUY Chart

People also search for

Salvatore Ferragamo S.p.A.
$ 5.6
0%
Zeon Corporation - Unsponsored ADR
$ 9.73
0%
Shangri-La Asia Limited Sponsored ADR
$ 10.4
0%
Telecom Italia S.p.A. Sponsored ADR
$ 8.74
+1.6279%
Pandora A/S Sponsored ADR
$ 15.4
-1.7795%

Hisamitsu Pharmaceutical Co., Inc. Unsponsored ADR (HTSUY) FAQ

What is the stock price today?

The current price is $2.94.

On which exchange is it traded?

Hisamitsu Pharmaceutical Co., Inc. Unsponsored ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is HTSUY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.76%.

What is its market cap?

As of today, the market cap is 839.03M.

Has Hisamitsu Pharmaceutical Co., Inc. Unsponsored ADR ever had a stock split?

Hisamitsu Pharmaceutical Co., Inc. Unsponsored ADR had 1 splits and the recent split was on Sep 06, 2017.

Hisamitsu Pharmaceutical Co., Inc. Unsponsored ADR Profile

Specialty Retail Industry
Consumer Discretionary Sector
Kazuhide Nakatomi CEO
OTC PINK Exchange
43358N107 CUSIP
JP Country
2,769 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Hisamitsu Pharmaceutical Co., Inc. is a distinguished pharmaceutical company based in Japan. Founded in 1847, it specializes in the manufacture and distribution of pharmaceutical products. The company is renowned for its production of external pain-relieving drugs and has achieved global reach, exporting its varied product range to approximately 40 countries and regions across Asia, the United States of America, and Europe. Hisamitsu Pharmaceutical Co., Inc. is headquartered in Tosu, Japan, marking its longevity and sustained relevance in the pharmaceutical industry with significant contributions to health and wellness worldwide.

Products and Services

  • External Pain-Relieving Drugs:

    Hisamitsu Pharmaceutical Co., Inc. offers a wide range of external pain-relieving products under brand names such as SALONPAS, NOBINOBI, SALONSIP, AIR, FEITAS, catering to various pain relief needs. These products are designed to provide relief from muscle and joint pains, utilizing topical technologies for consumer health care.

  • BUTENALOCK:

    A specially formulated medication for the treatment of athlete's foot, BUTENALOCK addresses the need for effective antifungal solutions, evidencing Hisamitsu's commitment to addressing a range of health care needs beyond pain relief.

  • ALLEGRA FX:

    This sinus medication is tailored for individuals suffering from allergies, providing relief from sinus pressure and symptoms associated with allergic reactions. ALLEGRA FX exemplifies Hisamitsu's endeavor to support those battling seasonal or chronic allergies.

  • Quasi-Drugs and Cosmetics:

    Hisamitsu's portfolio also includes a range of quasi-drugs and cosmetics, diversifying its offerings to meet the broader wellness and aesthetic needs of its customers, adhering to the high standards of safety and efficacy.

  • MOHRUS TAPE and MOHRUS PAP XR:

    These transdermal analgesic and anti-inflammatory drugs offer innovative solutions for pain management, allowing for the direct application of medication to the affected area through the skin, thus ensuring targeted relief and treatment.

  • Patches for Various Health Issues:

    Hisamitsu manufactures patches designed for the treatment of specific health conditions, including female hormone-related issues, asthma, and overactive bladders. These patches are part of Hisamitsu's specialized offerings that cater to the unique health care needs of individuals.

Contact Information

Address: 408 Tashirodaikan-machi
Phone: +81 3 5293 1700